Dealing with cancer screening in the covid-19 era
| dc.creator | Thales Pardini Fagundes | |
| dc.creator | Ronniel Morais Albuquerque | |
| dc.creator | Diego Lopes Paim Miranda | |
| dc.creator | Luciana Castro Garcia Landeiro | |
| dc.creator | Gabriel Souza Fontes Ayres | |
| dc.creator | Caenna Corrêa e Correia | |
| dc.creator | Angélica Nogueira Rodrigues | |
| dc.date.accessioned | 2023-08-14T21:21:00Z | |
| dc.date.accessioned | 2025-09-08T22:48:45Z | |
| dc.date.available | 2023-08-14T21:21:00Z | |
| dc.date.issued | 2021 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.1590/1806-9282.67 | |
| dc.identifier.issn | 18069282 | |
| dc.identifier.uri | https://hdl.handle.net/1843/57817 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Revista da Associação Médica Brasileira | |
| dc.rights | Acesso Aberto | |
| dc.subject | Detecção Precoce de Câncer | |
| dc.subject | Pandemias | |
| dc.subject | Infecções por Coronavirus | |
| dc.subject.other | Early detection of cancer | |
| dc.subject.other | Pandemics | |
| dc.subject.other | Coronavirus Infections | |
| dc.subject.other | Neoplasms | |
| dc.title | Dealing with cancer screening in the covid-19 era | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 90 | |
| local.citation.issue | 1 | |
| local.citation.spage | 86 | |
| local.citation.volume | 67 | |
| local.description.resumo | OBJECTIVE: This article aims to alert health professionals for cancer screening in the face of the possibility of new waves of disease. METHODS: A narrative review was conducted through a search in MEDLINE, Lilacs, Chinese Biomedical Literature Database, and international medical societies publications. RESULTS: Breast cancer: in high-risk patients (confirmed familial cancer syndrome or with high-risk tools scores), clinicians should act according to usual recommendations; in average-risk individuals, consider screening with mammography with a longer time span (maximum of two years). Cervical cancer: women turning 25 years old who have already been immunized and with no previous Pap test can have the test postponed during the pandemic; if there is no previous dose of Human Papillomavirus vaccination, initiation of screening should be recommended following a more rigid approach for COVID prevention; in women over 30 years of age who have never participated in cervical screening, the first screening exam is also essential. Colorectal cancer: if the individual is at elevated risk for familial cancer, the screening with colonoscopy according to usual recommendations should be supported; if at average risk consider screening with Fecal Occult Blood Test. Prostate cancer: there is a trend to postpone routine prostate cancer screening until the pandemic subsides. CONCLUSIONS: The decision to keep cancer screening must be discussed and individualized, considering the possibility of new waves of COVID-19. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | http://https://www.scielo.br/j/ramb/a/5cXbV6J5xSB6mnPCs68X4nz/?lang=endoi:10.1590/1806-9282.67 |